hbot

Individualized Algorithm-Based Intermittent Hypoxia Improves Quality of Life in Patients Suffering from Long-Term Sequelae After COVID-19 Infection Abstract Background/Objectives: Post-COVID-19 condition (PCC), also known as long COVID, has emerged as a recognized syndrome affecting millions...

Immediate and Long-Term Effects of Hyperbaric Oxygenation in Patients with Long COVID-19 Syndrome Using SF-36 Survey and VAS Score: A Clinical Pilot Study Abstract (1) Background: Long COVID syndrome (LCS) is a heterogeneous long-standing condition following COVID-19 infection. Treatment...

ME/CFS and the thalamus as a precision gate: what reversible thalamocortical connectivity reveals about central gain in post-infectious fatigue Strube, Andreas Abstract Kim and colleagues report a finding that is easy to understate: thalamic hyperconnectivity with sensorimotor and...

Community-delivered hyperbaric oxygen therapy for people affected by long COVID: a pilot study Abstract Long COVID is an umbrella term commonly used to describe a range of symptoms, such as chronic fatigue, ‘brain fog’ and breathlessness, that persist for at least 12 weeks after acute...

Hyperbaric Oxygen Therapy on Long COVID Symptoms: A Breath of Fresh Air Abstract Long COVID is defined as “the continuation or development of new symptoms 3 months after the initial SARS-CoV-2 infection, with these symptoms lasting for at least 2 months with no other explanations”, as...

Now published - link here Preprint Hyperbaric oxygen therapy improves clinical symptoms and functional capacity and restores thalamic connectivity in ME/CFS BACKGROUND Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disorder characterized by profound fatigue...

Effect of normobaric and hyperbaric hyperoxia treatment on symptoms and cognitive capacities in Long COVID patients: a randomised placebo-controlled, prospective, double-blind trial Leen D’hoore, Peter Germonpré, Bert Rinia, Leonard Caeyers, Nancy Stevens, Costantino Balestra [Line breaks...

Ten sessions of hyperbaric oxygen versus sham treatment in patients with long covid HOT-LoCO: a randomised, placebo-controlled, double-blind, phase II trial Anders Kjellberg; Adrian Hassler; Emil Boström; Sara El Gharbi; Sarah Al-Ezerjawi; Anna Schening; Katarina Fischer; Jan H Kowalski; Kenny A...

Long term outcomes of hyperbaric oxygen therapy in post covid condition: longitudinal follow-up of a randomized controlled trial Hadanny, Amir; Zilberman-Itskovich, Shani; Catalogna, Merav; Elman-Shina, Karin; Lang, Erez; Finci, Shachar; Polak, Nir; Shorer, Ran; Parag, Yoav; Efrati, Shai In our...

The effect of hyperbaric oxygen therapy on myocardial function in post-COVID-19 syndrome patients: a randomized controlled trial Leitman, Marina; Fuchs, Shmuel; Tyomkin, Vladimir; Hadanny, Amir; Zilberman-Itskovich, Shani; Efrati, Shai Post-COVID-19 condition refers to a range of persisting...

Abstract Post-COVID-19 condition refers to a range of persisting physical, neurocognitive, and neuropsychological symptoms after SARS-CoV-2 infection. The mechanism can be related to brain tissue pathology caused by virus invasion or indirectly by neuroinflammation and hypercoagulability. This...

Abstract Background Long COVID is a common occurrence following COVID-19 infection. The most common symptom reported is fatigue. Limited interventional treatment options exist. We report the first evaluation of hyperbaric oxygen therapy (HBOT) for long COVID treatment. Methods A total of 10...

This is all I have at the moment. It is noted as being "Image of the month". Paywall, https://link.springer.com/article/10.1007/s00259-020-05122-0

Source: European Underwater and Baromedical Society Date: March 1, 2019 URL: https://eubs2019.com Hyperbaric Medicine & The Brain Conference ------------------------------------------ 09-12 September 2019, Tel Aviv (...) The emerging indications related to hyperbaric oxygen and the brain...

Open access at https://www.frontiersin.org/articles/10.3389/fpsyg.2018.00848/full